Press Releases

Coloplast Acquires Mpathy Medical And Strengthens The Company's Position Within Female Pelvic Health

 

HUMLEBAEK, Denmark and MINNEAPOLIS, Oct. 29, 2010 (GLOBE NEWSWIRE) -- Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.

Mpathy Medical gives Coloplast the lightest weight mesh technologies in the world, less invasive pelvic restoration procedures, and an increased presence in the U.S. female pelvic health specialties market.

The Mpathy Medical acquisition is important in Coloplast's strategy to build a strong market presence within the highly competitive USD 500m, US and EU female pelvic health specialties market. The acquisition positions Coloplast for technology leadership and accelerated growth.

"I am very happy to announce this mutually beneficial acquisition," said Dave Amerson, Global Vice President, Coloplast Surgical Urology. "The acquisition of Mpathy will strengthen our presence in the female pelvic health market and raise the standard for innovation and patient outcomes in this market worldwide. We will leverage the strengths and best practices of both companies, which will give our customers access to an even stronger product portfolio and innovative solutions for restoring female pelvic health."

Coloplast will combine the two companies' complementary products into the Coloplast Surgical Urology division.

"I'm very proud of Mpathy's accomplishments," said James Browning, MD, founder and chief technology officer of Mpathy Medical, "and by being a part of Coloplast, we will improve our ability to provide technologically advanced surgical solutions to physicians, and improve outcomes for women."

Coloplast will pursue an integration of personnel, operations and products designed to ensure business continuity and exceptional customer service.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,454.83 1,317.82 2,837.53 17.45
Oil *
107.61
DOWN
74.92
DOWN
2.86
DOWN
1.85
DOWN
0.14
10 Yr
1.74%
SPDR Gold
152.68
-0.60%
-0.22%
-0.07%
-0.80%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet